FCE PHARMA IN SÃO PAULO
Brazil has become a significant growth driver for the pharma industry: rising prosperity there is steadily increasing the demand for high-value medicines. That’s why Fette Compacting’s new FE75 tablet press had to be presented at FCE Pharma, the industry’s main fair in Latin America. As a result, its presentation from Interpack was shown to the FCE trade show in Brazil.
“We definitely wanted to facilitate the presentation of the FE75 to FCE Pharma so our customers in Brazil could see the current development of the FE series,” explains Edilson Viola, Managing Director of Fette Compacting América Latina (FCAL). The latest studies highlight the market trend in Brazil: according to IMS Health, the value of sales in the Brazilian pharma market rose by 18.5% in 2013 to a total of roughly USD 57 billion. Germany Trade and Invest estimates that the country’s entire pharmaceutical market volume will double between 2012 and 2017.
Presentation of FE75 via video
FCE Pharma, which was held this year in São Paulo from 12 to 14 May, is Latin America’s most important fair for pharmaceutical industry technologies. The pharmaceutical industry’s entire production chain is on show here. Thanks to the video material from Düsseldorf, the tableting specialists of Fette Compacting America Latina, which is based in Campinas, Brazil, were also able to present the FE75.
The FE75 produces over 1.6 million tablets per hour and is therefore the world’s most productive tablet press. Furthermore, it only requires two square meters of floor space. That is an ideal starting point for South American pharmaceutical manufacturers that produce tablets in large batches: their facilities can maximize their potential output and even hold space in reserve for future growth.
“We received a lot of positive feedback about the video presentation at FCE Pharma,” reports Edilson Viola about the new approach. “The visitors were evidently impressed by the high performance of this technology. We are confident that the FE75 will firmly establish itself on the Brazilian market over the next few years.”